Abstract

In fungi, the Mitogen-Activated Protein kinase (MAPK) pathways sense a wide variety of environmental stimuli, leading to cell adaptation and survival. The HOG pathway plays an essential role in the pathobiology of Candida albicans, including the colonization of the gastrointestinal tract in a mouse model, virulence, and response to stress. Here, we examined the role of Hog1 in the C. albicans response to the clinically relevant antifungal Micafungin (MF), whose minimum inhibitory concentration (MIC) was identical in the parental strain (RM100) and in the isogenic homozygous mutant hog1 (0.016 mg/L). The cell viability was impaired without significant differences between the parental strain, the isogenic hog1 mutant, and the Hog1+ reintegrant. This phenotype was quite similar in a collection of hog1 mutants constructed in a different C. albicans background. MF-treated cells failed to induce a relevant increase of both reactive oxygen species (ROS) formation and activation of the mitochondrial membrane potential in parental and hog1 cells. MF was also unable to trigger any significant activation of the genes coding for the antioxidant activities catalase (CAT1) and superoxide dismutase (SOD2), as well as on the corresponding enzymatic activities, whereas a clear induction was observed in the presence of Amphotericin B (AMB), introduced as a positive control of Hog1 signaling. Furthermore, Hog1 was not phosphorylated by the addition of MF, but, notably, this echinocandin caused Mkc1 phosphorylation. Our results strongly suggest that the toxic effect of MF on C. albicans cells is not mediated by the Hog1 MAPK and is independent of the generation of an internal oxidative stress in C. albicans.

Highlights

  • Candida albicans is an inhabitant of the human microbiota with a huge potential to cause damage

  • In order to elucidate if Hog1-mediated oxidative stress plays any significant role in the MF action mechanism against C. albicans, we analyzed the effect of this echinocandin on a hog1 null mutant, previously reported to be hypersensitive to oxidants [29]

  • These data strongly support that the implication of the HOG pathway in the C. albicans response to MF is essentially different to that recently reported against Amphotericin B (AMB), which was introduced here as the control

Read more

Summary

Introduction

Candida albicans is an inhabitant of the human microbiota with a huge potential to cause damage. This fungus causes superficial infections that can affect almost any mucosal surface of the body. Whereas the resistance to AMB remains episodic more than 60 years after its introduction in the medical practice [11], the increasing isolation of strains resistant to azoles and echinocandins raises new difficulties in antifungal chemotherapy, considering hospital-growing opportunistic infections [12,13]. Many clinical isolates of C. glabrata and C. auris display cross-resistance between echinocandins and azoles. This finding allows explaining their growing presence as fungal bloodstream pathogens

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call